| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 18 |
| 1 | METHYLPHENIDATE | 14 |
| 2 | LEVONORGESTREL | 4 |
| 3 | IDURSULFASE | 3 |
| 4 | LORAZEPAM | 3 |
| 5 | TREPROSTINIL | 3 |
| 6 | ALBUTEROL SULFATE | 2 |
| 7 | AMBRISENTAN | 2 |
| 8 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 2 |
| 9 | CARBIDOPA AND LEVODOPA | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACITRACIN ZINC AND POLYMYXIN B SULFATE | 1 | 0.0090 |
| 1 | CEFPROZIL | 1 | 0.0013 |
| 2 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 3 | IDURSULFASE | 3 | 0.0008 |
| 4 | ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE | 1 | 0.0006 |
| 5 | NEOMYCIN OINTMENT | 1 | 0.0004 |
| 6 | ARIPIPRAZOLE LAUROXIL | 1 | 0.0002 |
| 7 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 8 | BUPRENORPHINE | 18 | 0.0002 |
| 9 | SIPULEUCEL-T | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 2 | Partial Opioid Agonist [EPC] | 18 | 0.0002 |
| 3 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 4 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 5 | Central Nervous System Stimulant [EPC] | 14 | 0.0002 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |